A nationwide cross-sectional study in China found that prevention of mother-to-child transmission success rates for hepatitis B virus remained above 99.6 percent between 2023 and 2025, while revealing that 37.77 percent of residual pediatric infections exhibited concurrent surface antibodies.
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.